Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 156 participants.
Also called NCT06750341
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 156 participants
- Registry
-
NCT06750341
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06750341. Randomized; quadruple masking; primary purpose treatment. Start 2025-02 (anticipated); primary completion 2026-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol
- Condition
- Primary Hypercholesterolemia or Mixed Hyperlipidemia
- Intervention (Drug)
- QLC7401
- Intervention (Drug)
- Placebo
- Lead sponsor
- Qilu Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct06750341- Content hash
36c95ec510bd085cfa8f709e0d4d6324c0edc0d691bdebef980c30ebcde121ad